ogttMetrics
ogttMetrics computes quantitative measures of glucose metabolism from oral glucose tolerance test (OGTT) data for use in clinical and epidemiological studies.
Key Features:
- Data organization and visualization: Organizes OGTT datasets and provides visualization of time-series glucose and insulin measurements.
- Comparative analysis: Enables group-level comparisons of OGTT-derived metrics across cohorts and study groups.
- Parameter estimation (Bergman minimal model): Implements parameter estimation for the Bergman minimal model and addresses numerical difficulties with alternative estimation approaches.
- Simplified indices (Matsuda index): Computes closed-form indices such as the Matsuda index as a simplified proxy for insulin sensitivity.
Scientific Applications:
- Clinical trials: Evaluates effects of interventions on OGTT-derived glucose and insulin metrics in clinical studies.
- Epidemiological and cohort studies: Supports large-scale analyses of glucose metabolism and insulin sensitivity in population cohorts.
- Dietary intervention and glycemic index research: Assesses effects of dietary carbohydrate content and glycemic index on OGTT responses.
- Insulin sensitivity assessment and diabetes risk stratification: Ranks individuals by insulin sensitivity and aids identification of risk factors for diabetes and metabolic disorders.
Methodology:
Computational methods include calculation of multiple OGTT-derived measures, parameter estimation for the Bergman minimal model with attention to numerical issues and alternative estimation approaches, computation of closed-form indices such as the Matsuda index, and handling of large OGTT datasets for group comparisons.
Topics
Details
- License:
- GPL-3.0
- Tool Type:
- library
- Programming Languages:
- R
- Added:
- 8/21/2018
- Last Updated:
- 12/10/2018
Operations
Publications
Stubbs BJ, Frankston K, Ramos M, Laranjo N, Sacks FM, Carey VJ. ogttMetrics: Data structures and algorithms for oral glucose tolerance tests. F1000Research. 2017;6:684. doi:10.12688/f1000research.11317.1.
Funding: - National Institute of Diabetes and Digestive and Kidney Diseases: 5R21DK098720-02
- National Cancer Institute: 5U24 CA180996-04